within Pharmacolibrary.Drugs.ATC.H;

model H02AB04
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00017666666666666666,
    adminDuration  = 600,
    adminMass      = 36 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0384,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.037700000000000004,
    k12             = 13.8,
    k21             = 13.8
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>H02AB04</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Methylprednisolone is a synthetic glucocorticoid corticosteroid drug with potent anti-inflammatory and immunosuppressive properties. It is widely used to treat conditions such as allergic reactions, autoimmune diseases, certain types of arthritis, and is also employed in transplant rejection prophylaxis. It is approved and commonly used in clinical practice today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after intravenous bolus injection.</p><h4>References</h4><ol><li><p>Czock, D, et al., &amp; Häussler, U (2005). Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. <i>Clinical pharmacokinetics</i> 44(1) 61–98. DOI:<a href=\"https://doi.org/10.2165/00003088-200544010-00003\">10.2165/00003088-200544010-00003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/15634032/\">https://pubmed.ncbi.nlm.nih.gov/15634032</a></p></li><li><p>Sinha, A, &amp; Bagga, A (2008). Pulse steroid therapy. <i>Indian journal of pediatrics</i> 75(10) 1057–1066. DOI:<a href=\"https://doi.org/10.1007/s12098-008-0210-7\">10.1007/s12098-008-0210-7</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/19023530/\">https://pubmed.ncbi.nlm.nih.gov/19023530</a></p></li><li><p>Al-Habet, SM, &amp; Rogers, HJ (1989). Methylprednisolone pharmacokinetics after intravenous and oral administration. <i>British journal of clinical pharmacology</i> 27(3) 285–290. DOI:<a href=\"https://doi.org/10.1111/j.1365-2125.1989.tb05366.x\">10.1111/j.1365-2125.1989.tb05366.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2655680/\">https://pubmed.ncbi.nlm.nih.gov/2655680</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end H02AB04;
